newsA new, high-tech, sustainable biologics manufacturing facility at Genentech’s US…
15 February 2023 | By Catherine Eckford (European Pharmaceutical Review)
A new, high-tech, sustainable biologics manufacturing facility at Genentech’s US Oceanside campus will be operational in early 2025.